These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
193 related articles for article (PubMed ID: 34932218)
1. Antagonists targeting eEF2 kinase rescue multiple aspects of pathophysiology in Alzheimer's disease model mice. Kasica NP; Zhou X; Yang Q; Wang X; Yang W; Zimmermann HR; Holland CE; Koscielniak E; Wu H; Cox AO; Lee J; Ryazanov AG; Furdui CM; Ma T J Neurochem; 2022 Mar; 160(5):524-539. PubMed ID: 34932218 [TBL] [Abstract][Full Text] [Related]
2. Genetic reduction of eEF2 kinase alleviates pathophysiology in Alzheimer's disease model mice. Beckelman BC; Yang W; Kasica NP; Zimmermann HR; Zhou X; Keene CD; Ryazanov AG; Ma T J Clin Invest; 2019 Feb; 129(2):820-833. PubMed ID: 30667373 [TBL] [Abstract][Full Text] [Related]
3. Suppression of eEF2 phosphorylation alleviates synaptic failure and cognitive deficits in mouse models of Down syndrome. Wang X; Yang Q; Zhou X; Keene CD; Ryazanov AG; Ma T Alzheimers Dement; 2024 Aug; 20(8):5357-5374. PubMed ID: 38934363 [TBL] [Abstract][Full Text] [Related]
4. Roles of eukaryotic elongation factor 2 kinase (eEF2K) in neuronal plasticity, cognition, and Alzheimer disease. Ma T J Neurochem; 2023 Jul; 166(1):47-57. PubMed ID: 34796967 [TBL] [Abstract][Full Text] [Related]
5. Suppression of the kinase for elongation factor 2 alleviates mGluR-LTD impairments in a mouse model of Alzheimer's disease. Yang W; Zhou X; Ryazanov AG; Ma T Neurobiol Aging; 2021 Feb; 98():225-230. PubMed ID: 33341653 [TBL] [Abstract][Full Text] [Related]
7. Homozygous knockout of eEF2K alleviates cognitive deficits in APP/PS1 Alzheimer's disease model mice independent of brain amyloid β pathology. Kasica NP; Zhou X; Jester HM; Holland CE; Ryazanov AG; Forshaw TE; Furdui CM; Ma T Front Aging Neurosci; 2022; 14():959326. PubMed ID: 36158543 [TBL] [Abstract][Full Text] [Related]
8. Investigating Eukaryotic Elongation Factor 2 Kinase/Eukaryotic Translation Elongation Factor 2 Pathway Regulation and Its Role in Protein Synthesis Impairment during Disuse-Induced Skeletal Muscle Atrophy. Vilchinskaya N; Lim WF; Belova S; Roberts TC; Wood MJA; Lomonosova Y Am J Pathol; 2023 Jun; 193(6):813-828. PubMed ID: 36871751 [TBL] [Abstract][Full Text] [Related]
9. Inhibition of AMP-activated protein kinase signaling alleviates impairments in hippocampal synaptic plasticity induced by amyloid β. Ma T; Chen Y; Vingtdeux V; Zhao H; Viollet B; Marambaud P; Klann E J Neurosci; 2014 Sep; 34(36):12230-8. PubMed ID: 25186765 [TBL] [Abstract][Full Text] [Related]
10. Repression of eEF2K transcription by NF-κB tunes translation elongation to inflammation and dsDNA-sensing. Bianco C; Thompson L; Mohr I Proc Natl Acad Sci U S A; 2019 Nov; 116(45):22583-22590. PubMed ID: 31636182 [TBL] [Abstract][Full Text] [Related]
11. Phosphorylation of eukaryotic elongation factor 2 (eEF2) by cyclin A-cyclin-dependent kinase 2 regulates its inhibition by eEF2 kinase. Hizli AA; Chi Y; Swanger J; Carter JH; Liao Y; Welcker M; Ryazanov AG; Clurman BE Mol Cell Biol; 2013 Feb; 33(3):596-604. PubMed ID: 23184662 [TBL] [Abstract][Full Text] [Related]
12. Synaptic activity controls dendritic spine morphology by modulating eEF2-dependent BDNF synthesis. Verpelli C; Piccoli G; Zibetti C; Zanchi A; Gardoni F; Huang K; Brambilla D; Di Luca M; Battaglioli E; Sala C J Neurosci; 2010 Apr; 30(17):5830-42. PubMed ID: 20427644 [TBL] [Abstract][Full Text] [Related]
13. Repression of eEF2 kinase improves deficits in novel object recognition memory in aged mice. Gosrani SP; Jester HM; Zhou X; Ryazanov AG; Ma T Neurobiol Aging; 2020 Nov; 95():154-160. PubMed ID: 32810756 [TBL] [Abstract][Full Text] [Related]
14. A Ca(2+)-calmodulin-eEF2K-eEF2 signalling cascade, but not AMPK, contributes to the suppression of skeletal muscle protein synthesis during contractions. Rose AJ; Alsted TJ; Jensen TE; Kobberø JB; Maarbjerg SJ; Jensen J; Richter EA J Physiol; 2009 Apr; 587(Pt 7):1547-63. PubMed ID: 19188248 [TBL] [Abstract][Full Text] [Related]
15. A decrease in eukaryotic elongation factor 2 phosphorylation is required for local translation of sensorin and long-term facilitation in Aplysia. McCamphill PK; Ferguson L; Sossin WS J Neurochem; 2017 Jul; 142(2):246-259. PubMed ID: 28345161 [TBL] [Abstract][Full Text] [Related]
16. Lopinavir impairs protein synthesis and induces eEF2 phosphorylation via the activation of AMP-activated protein kinase. Hong-Brown LQ; Brown CR; Huber DS; Lang CH J Cell Biochem; 2008 Oct; 105(3):814-23. PubMed ID: 18712774 [TBL] [Abstract][Full Text] [Related]
17. Direct and indirect activation of eukaryotic elongation factor 2 kinase by AMP-activated protein kinase. Johanns M; Pyr Dit Ruys S; Houddane A; Vertommen D; Herinckx G; Hue L; Proud CG; Rider MH Cell Signal; 2017 Aug; 36():212-221. PubMed ID: 28502587 [TBL] [Abstract][Full Text] [Related]
18. Eukaryotic elongation factor 2 (eEF2) kinase/eEF2 plays protective roles against glucose deprivation-induced cell death in H9c2 cardiomyoblasts. Kameshima S; Okada M; Yamawaki H Apoptosis; 2019 Apr; 24(3-4):359-368. PubMed ID: 30737648 [TBL] [Abstract][Full Text] [Related]
19. Levels of mTOR and its downstream targets 4E-BP1, eEF2, and eEF2 kinase in relationships with tau in Alzheimer's disease brain. Li X; Alafuzoff I; Soininen H; Winblad B; Pei JJ FEBS J; 2005 Aug; 272(16):4211-20. PubMed ID: 16098202 [TBL] [Abstract][Full Text] [Related]
20. A functional eEF2K-eEF2 pathway in the NAc is critical for the expression of cocaine-induced psychomotor sensitisation and conditioned place preference. Beiser T; Lisniansky E; Weitz M; Bingor A; Grad E; Rosenblum K; Thornton C; Yaka R Transl Psychiatry; 2022 Nov; 12(1):460. PubMed ID: 36319619 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]